DEFINITIVE PROXY STATEMENT

Company

Protalix BioTherapeutics, Inc.

Filed

December 31, 2007

Period of Report

January 31, 2008

Accession Number

0000950136-07-008573

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →